Artelo Biosciences Q3 EPS $(0.10) Up From $(0.27) YoY

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.10) per share. This is a 62.96 percent increase over losses of $(0.27) per share from the same period last year.

byBenzinga Newsdesk

July 12, 2021

1 minute read

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.10) per share. This is a 62.96 percent increase over losses of $(0.27) per share from the same period last year.

KKR’s A$14.5B Takeover Bid Of Australia’s Ramsay Health Care Hits A Snag

By Vandana Singh

Today, 5:35 AM

Talks regarding KKR & Co (NYSE:KKR)-led consortium buying Australian hospital operator Ramsay Health Care Ltd (OTC:RMSYF) (OTC:RMYHY) have hit a snag. The consortium…

KKR

The9 to Acquire Canadian Crypto Mining Facilities Company Montcrypto for $C$7.6M

By Anusuya Lahiri

Today, 5:35 AM

Chinese internet company The9 Ltd (NASDAQ:NCTY) inked an agreement to acquire Canada’s Montcrypto Ltd to build a 20MW electricity supply in Calgary,…

NCTY

Schwazze Adds Key Hires To Senior Leadership Team

By Benzinga Newsdesk

Today, 5:35 AM

Schwazze, (OTCQX: SHWZ) announced the addition of key roles to support the company's significant expansion within manufacturing, cultivation, and information technology.

SHWZ

News

Looking Into Opiant Pharmaceuticals’s Return On Capital Employed

By Benzinga Insights

Today, 5:35 AM

In Q1, Opiant Pharmaceuticals (NASDAQ:OPNT) posted sales of $6.39 million. Earnings were up 152.19%, but Opiant Pharmaceuticals still reported an overall loss of $2.32 million. In Q4, Opiant Pharmaceuticals brought in $9.92 million in sales but lost $920.52 thousand in earnings.

OPNT

Artelo Biosciences Q3 EPS $(0.10) Up From $(0.27) YoY

Related Posts

KKR’s A$14.5B Takeover Bid Of Australia’s Ramsay Health Care Hits A Snag

The9 to Acquire Canadian Crypto Mining Facilities Company Montcrypto for $C$7.6M

Schwazze Adds Key Hires To Senior Leadership Team

Looking Into Opiant Pharmaceuticals’s Return On Capital Employed